Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMox: Carbetocin vs Syntocinon vs Syntometrine for PPH Prevention
NCT02216383Phase 3Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Feb 2015
- Primary completion
- Aug 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (3 arms), sponsored by North Bristol NHS Trust. Primary endpoint: Requirement for additional uterotonic drugs within 24 hours of birth. Started Feb 2015; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02216383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216383.